The researchers established an adjuvant‐induced arthritis mouse model and found that intraperitoneal injection of the tyrosine kinase inhibitor AG126 reduced the number of CD8+ T cells and increased the number of Treg cells in the knee joints of the mice, significantly reducing the severity of arthritis.34 Here, CD8A is linked to arthritic joint disease.